NCT00704366View on ClinicalTrials.gov

AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

May 31, 2011

Conditions
Solid Tumor
Interventions
DRUG

AZD0530

oral, tablet, once daily, dose will be variable

Trial Locations (2)

Unknown

Research Site, Takatsuk

Research Site, Sunto-gun

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00704366 - AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours | Biotech Hunter | Biotech Hunter